You Searched For "gilead remdesivir" and got 18 results
Sort By:
2 mins read
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
2 mins read
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
1 min read
Gilead soars 11% after reporting positive news on potential coronavirus treatment
Antiviral remdesivir is the leading hope of a coronavirus treatment, as other drugs have disappoint…
Carmen Reinicke
2 mins read
Gilead surges 17% on report that drug shows effectiveness against COVID-19
In a Chicago hospital, all patients with Covid-19 treated with Gilead's Remdesivir were discharged …
Carmen Reinicke
3 mins read
The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients
If the inhaled version of remdesivir works, it "could have significant implications in helping to s…
Andrew Dunn
2 mins read
The biotech giant Gilead just laid out its pricing strategy for the first effective coronavirus treatment, and it's charging up to $520 a vial for remdesivir
Governments of developed countries will pay $2,340 for a five-day course of the antiviral drug remd…
Andrew Dunn
2 mins read
Gilead rises after pricing its coronavirus-fighting drug remdesivir
"We believe that pricing remdesivir well below value is the right and responsible thing to do," sai…
Carmen Reinicke
5 mins read
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
2 mins read
Gilead slides 4% after COVID-19 drug shows limited benefit in moderately ill patients
Patients who received remdesivir for five days were 65% more likely to show signs of recovery than …
Saloni Sardana
2 mins read
Gilead tanks 9% on report its coronavirus drug doesn't help patients
The report contained "inappropriate characterizations," Gilead said, adding that low enrollment led…
Ben Winck
3 mins read
US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results
FDA is reportedly preparing to allow emergency use of remdesivir as soon as today. The treatment he…
Andrew Dunn
3 mins read
The US government's supply of remdesivir — the only drug proved to treat the coronavirus — is due to run out at the end of June
The number of US COVID-19 patients requiring remdesivir outnumbers available stocks by two to one, …
Bill Bostock
1 min read
Batches of the COVID-19 treatment drug Remdesivir were recalled after glass particles were found in some vials
Biopharmaceutical company Gilead Sciences announced that two lots of Remdesivir are being recalled …
Cheryl Teh
1 min read
Gilead's coronavirus treatment remdesivir just succeeded in a crucial study, raising hopes for a first COVID-19 drug
One of the most promising coronavirus treatment candidates succeeded in a late-stage trial in COVID…
Andrew Dunn
1 min read
COVID-19: Jubilant Life inks licensing agreement with Gilead for remdesivir
The EUA is based on available data from two global clinical trials -- US National Institute for Al…
PTI
2 mins read
Gilead sold $873 million worth of its antiviral COVID-19 treatment even though data on its success remains mixed
Gilead posted its first numbers detailing how much money the pharmaceutical company has made throug…
Allana Akhtar
3 mins read
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…
Andrew Dunn
6 mins read
The 'most promising' coronavirus treatment faces its biggest test yet. Clinical data for Gilead's drug remdesivir is coming in a matter of weeks.
In that account, the patient who was the first confirmed case of COVID-19 in the US received remdes…